The prevalence, management and burden of asthma - A nigerian study

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 1, 2010, Pages 35-41

  Oni, Alexander Osaretin ^a   Erhabor, G E ^b   Egbagbe, E E ^c  

^a Niger Delta University Teaching Hospital   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Airway resistance; Burden; Chronic inflammation; Co morbidities; Poor asthma treatment; Prevalence

Indexed keywords

BRONCHODILATING AGENT; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; BODY BURDEN; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DERMATITIS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; GROUPS BY AGE; HOSPITALIZATION; HOUSEHOLD; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PHARYNGITIS; PHYSICAL ACTIVITY; PREVALENCE; RHINITIS; SLEEP DISORDER; SOCIAL BEHAVIOR; SPORT; STRUCTURED QUESTIONNAIRE; WORK;

ADULT; ASTHMA; COST OF ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; SEX FACTORS;

EID: 77954380414     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143-78
2. Rees J. ABC of asthma. Prevalence. BMJ 2005; 331(7514):443-5.
3. Tattersfield A E, Britton J R. β-Adrenocepter agonists. In: Barnes PJ, Rodger IW, Thomson NC, editors. Asthma: Basic Mechanisms and Clinical Management. London: Academic Press, 1992:527-54.
4. Castro HJ, Malka-Rais J, Bellanti JA. Current epidemiology of asthma: emerging patterns of asthma. Allergy Asthma Proc 2005; 26(2):79-82. (Pubitemid 40770066)
5. Lordan JL, Holgate ST. Recent developments in the pathogenesis and epidemiological trends of asthma. J R Coll Physicians Lond 1999; 33(5):418-25.
6. Fajt ML, Wenzel SE. Asthma phenotypes in adults and clinical implications. Expert Rev Respir Med 2009; 3(6):607-25.
7. Detjen P. Allergic Bronchopulmonary Aspergillosis. In: Lynch JP, editor. Immunologically Mediated Pulmonary Disease. USA: Lippincott Co, 1991.
8. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl): S94-138.
9. Falade AG, Olawuyi F, Osinusi K, Onadeko BO. Prevalence and severity of symptoms of asthma, allergic rhino-conjunctivitis and atopic eczema in secondary school children in Ibadan, Nigeria. East Afr Med J 1998; 75(12):695-8.
10. Ibe CC, Ele UP. Prevalence of bronchial asthma among adolescents in Anambra State, Nigeria.Nig J Int Med 2002; 5(1/2):23-6.
11. Irusen EM. Prevalence of asthma in various countries in the world. Presented at the Seretide "delivering the promise" conference, Abuja. August 2004.
12. Levy ML,Fletcher M,Price DB,Hausen T,Halbert RJ,Yawn BP.International Primary Care Respiratory Group(IPCRG)Guidelines:diagnosis of respiratory diseases in primary care. PRIM Care Respir J 2006; 15(1):20-34.
13. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests.Eur Respir J 2005; 26(5):948-68.
14. Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care 2001; 39(12):1326-38.
15. Rimington LD, Davies DH, Lowe D, Person MG. Relationship between anxiety, depression and morbidity in adult asthma patients. Thorax 2001; 56(4):266-71.
16. Serra-Batlles J, Plaza V, Morejón E, Comella A, Brugués J. Cost of asthma according to degree of severity.Eur Respir J 1998; 12(6):1322-6.
17. Ustovic A, Simpson BM, Murray CS, Lowe L, Woodcock A. The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol 2002; 13 Suppl 15:32-7.
18. National Asthma Council. 2002. Asthma management handbook. Melbourne: NAC, 2002.
19. Sapra SJ, Broder MS, Chang E. Alignment with the revised NHLBI 2007 asthma guidelines, Expert Panel Report 3 (EPR 3) in a large payer database. J Allergy Clin Immunol 2009; 123(2)(suppl1):S117.
20. Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, Soriano JB, et al. Asthma control in Latin America:the Asthma Insights and Reality in Latin America(AIRLA) survey.Rev Panam Salud Publica 2005; 17(3):191-7.
21. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults : the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114(1):40-7.
22. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59(5):469-78.
23. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14(1):902-7.
24. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. The influence of demographic and socioeconomic factors on health-related quality of life in asthma. J Allergy Clin Immunol 1999; 103(1 Pt 1):72-8.
25. Schmier JK, Chan KS, Leidy NK. The impact of asthma on health related quality of life.J asthma.1998; 35(7):585-97.
26. Ekerljung L, Lundback B. FinEsS-Stockholm and the Stockholm adult asthma study. Clin Respir J 2008; 2 Suppl 1:127-8.
27. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002; 57(7):569-74.
28. Brogger J, Bakke P, Eide GE, Johansen B, Andersen A, Gulsvik A. Long term changes in adult asthma prevalence.Eur Respir J 2003;21(3):468-72.
29. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16(5):802-7.
30. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey. J Allergy Clin Immunol 2002; 110(1):58-64. (Pubitemid 36132728)
31. Lai CK, De Guia TS, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB, et al. Asthma control in the Asia Pacific region:The Asthma Insights and Reality in Asia Pacific Study.J Allergy Clin Immunol 2003; 111(2):263-8.
32. Alsamarai MA, Alwan MA, Ahmad HA, Salih MA, Salih JA, Aldabagh MA et al. The relationship between asthma and allergic rhinitis in the Iraqi population.Allergology International.2009; 58(4):495-555.
33. Rahimi Rad MH, Hejazi ME, Behrouzian R. Asthma and other allergic diseases in 13-14-year-old schoolchildren in Urmia, Iran. East Mediterr Health J 2007; 13(5):1005-16.
34. Nayak AS. The asthma and allergic rhinitis link. Allergy Asthma Proc 2003; 24(6):395-402.
35. Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. EXCEL: a randomised trial comparing salmeterol/ fluticasone propionate and formoterol/ budesonide combinations in adults with persistent asthma. Respir Med 2006; 100(7):1152-62.
36. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effects of inhaled formoterol and budesonide on exacerbations of asthma.Formoterol and Corticosteroids Establishing Therapy(FACET) International Study Group. N Engl J Med 1997; 337(20):1405-11.
37. Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, et al. Efficacy,safety and effects on quality of life of persistent asthma. Ann Allergy Asthma Immunol 1998; 80(6):463-70.
38. Shrewsbury S, Pyke S, Britton M. Meta- analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000; 320(7246):1368-73.
39. Bateman ED, Bouquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007; 29(1):56-62.
40. Newnham DM, McDevitt DG, Lipworth BJ. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 1994; 97(1):29-37.
41. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The salmeterol Multicenter Asthma Research Trial:a comparism of usual pharmacotherapy plus salmeterol. Chest 2006; 129(1):29-37.